基于机器学习的STEMI患者的长期死亡率预测,使用临床,实验室和炎症代谢指数
Gökhan Keskin1, Abdulkadir Çakmak1, Mehmet Uğur Çalışkan1
1Department of Cardiology, Faculty of Medicine, Amasya University, Amasya 05200, Türkiye.
Journal of clinical medicine
|March 14, 2026
概括
机器学习模型XGBoost准确地预测了ST段升高心肌梗塞 (STEMI) 患者的长期死亡风险,这些患者正在接受一次性皮肤穿冠状动脉干预 (pPCI). 新的炎症代谢指数改善了风险分层.
科学领域:
- 心脏病学 心脏病学
- 人工智能的人工智能
- 医疗信息学 医疗信息学
背景情况:
- ST段升高心肌梗塞 (STEMI) 具有显著的长期死亡风险.
- 初级穿皮冠状动脉干预 (pPCI) 是STEMI的标准治疗方法.
- 准确预测死亡风险对于患者管理和治疗优化至关重要.
研究的目的:
- 为了比较各种机器学习 (ML) 模型在预测pPCI后STEMI患者的长期死亡率方面的表现.
- 在这个患者队列中评估新型炎症代谢指数的预后价值.
- 确定死亡率的关键预测因子,以改善风险分层.
主要方法:
- 对接受pPCI的329名STEMI患者进行了回顾性分析.
- 开发和比较五个ML算法:物流回归 (LR),随机森林 (RF),极端梯度增强 (XGBoost),支持向量机器 (SVM) 和人工神经网络 (ANN).
- 使用精度,灵敏度,特异性和ROC-AUC的性能评估;用于模型解释的SHAP分析.
主要成果:
- XGBoost模型表现出卓越的性能,准确度为98.99%,ROC-AUC为0.999,灵敏度为100%.
- 较高的门到气球时间 (DTBT),全身炎症反应指数 (SIRI) 和泛免疫炎症值 (PIV) 与死亡率有关.
- 在死亡率组中观察到下体质指数 (BMI),预后营养指数 (PNI) 和高级肺癌炎症指数 (ALI).
- SHAP分析确定了DTBT,白蛋白和ALI作为最强的死亡率预测因素.
结论:
- XGBoost算法是预测STEMI患者长期死亡率的高度准确和可靠的工具.
- 将新的炎症代谢指数 (如ALI和TyG) 与DTBT整合到ML模型中,可以提高早期风险识别和分层.
- 这些发现表明,通过先进的预测建模,可以改善临床决策和患者的治疗结果.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies
369
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
369
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
684
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
684

